-+ 0.00%
-+ 0.00%
-+ 0.00%

GALMED PHARMACEUTICALS LTD - PHASE 1B STUDY OF ARAMCHOL AND REGORAFENIB TO START Q4 2025

Reuters·05/06/2025 11:30:12

Please log in to view news